Overview
USD1 (USD1) and Injective (INJ) sit at different layers of the crypto stack. At current prices ($1.00 vs $4.99), market leadership still favors USD1 on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | USD1 | INJ |
|---|---|---|
| Price | $1.00 | $4.99 |
| Market Cap | $3.99B | $490.41M |
| FDV | — | — |
| Volume 24h | $57.61M | $2.65M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 24.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | USD1 | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.01% | +1.03% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | USD1 | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 65.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, USD1 shows RSI 49.02 with trend bias bearish, while Injective sits at RSI 49.29 (neutral). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | USD1 | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
USD1
Injective
Pros and cons
Pros of USD1
- USD1 often anchors narratives that attract sustained media and analyst coverage.
- USD1 typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Composite PEPS readings for USD1 can surface clearer module agreement during trend phases.
Cons of USD1
- Crowded positioning around USD1 sometimes amplifies squeeze or flush risk.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- When dominance narratives fade, USD1 can lag hotter rotation names.
Pros of Injective
- PEPS tracking for Injective still includes AI score and level context for monitoring.
- Diversifying versus USD1 with Injective can change portfolio factor exposure.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to USD1, while short-term performance leans toward Injective. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put USD1 at $1.00 and Injective at $4.99. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, USD1 or Injective?
“Better” depends on horizon and risk. USD1 leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, USD1 or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both USD1 and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. USD1 currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.